Coriolis Pharma

📍 Martinsried (Munich), Germany🗓 Founded 2008👥 178 employees💰 Last funded Oct 2023
Pharmaceutical Manufacturing🌐 coriolis-pharma.com
Website LinkedIn
Coriolis Pharma is a globally operating and science driven contract research and development organization (CRDO). We support drug product development of biopharmaceuticals, including gene and cell therapies and vaccines, from early development to commercialization. Our focus lies on formulation development, lyophilization technologies and analytics (GMP and non-GMP) for a wide range of products. As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients. We offer a large selection of services for all types of biopharmaceuticals, including proteins, peptides, peptides, nucleic acids, gene- and cell therapy products, vaccines and virus(-like) particles up to biosafety level S2.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2008
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Coriolis Pharma?
Coriolis Pharma has 1 investors on record on gritt.io.
When did Coriolis Pharma last raise funding?
The most recent investment in Coriolis Pharma recorded on gritt.io was in October 2023.
When was Coriolis Pharma founded?
Coriolis Pharma was founded in 2008.
What industry is Coriolis Pharma in?
Coriolis Pharma operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Coriolis Pharma based?
Coriolis Pharma is headquartered in Martinsried (Munich), Germany.